Podcasts about numerof

Dr. Rita Numerof, who appeared as a guest on Episode 27 of The Business of Healthcare Podcast, returns to discuss with host Dan Karnuta why it remains so difficult for value-based pricing to catch on in the healthcare industry. Numerof is an author, president and co-founder of healthcare consulting firm Numerof & Associates and a columnist at Forbes. Karnuta is director of the Professional Program in Healthcare Management at The University of Texas at Dallas Naveen Jindal School of Management. Links discussed on the episode: “Why Accountable Care Organizations Won't Deliver Better Healthcare  — and Market Innovation Will” (Heritage Foundation's Healthcare Reform Report)

Dr. Rita Numerof, who appeared as a guest on Episode 27 of The Business of Healthcare Podcast, returns to discuss with host Dan Karnuta why it remains so difficult for value-based pricing to catch on in the healthcare industry. Numerof is an author, president and co-founder of healthcare consulting firm Numerof & Associates and a columnist at Forbes. Karnuta is director of the Professional Program in Healthcare Management at The University of Texas at Dallas Naveen Jindal School of Management. Links discussed on the episode: “Why Accountable Care Organizations Won't Deliver Better Healthcare  — and Market Innovation Will” (Heritage Foundation's Healthcare Reform Report)

Ever wondered if you could put your STEM PhD to work in consulting? Kim White, Vice President and Senior Consultant with Numerof & Associates, certainly thinks so. Numerof & Assoc. is a strategy consulting firm that helps businesses across the life sciences sector develop and implement strategies for competitive advantage in dynamic markets. The firm has a number of PhDs on its staff, many from STEM backgrounds. Join us to hear about the work they do, about consulting in general, and advice about how to succeed in such a role.

In this episode, we are joined by Michael Abrams, the co-founder of Numerof to discuss their sixth Consecutive State of the Population Health Survey, which looks at the evolution of population health in the United States. Learn how to listen to The Hospital Finance Podcast® on your mobile device. Highlights of this episode include: Who Read More

Hosts Gregg Masters and Fred Goldstein meet Michael Abrams Managing Partner Numerof & Associates, and their discussion of the key take-aways of their recent report: State of Population Health: The 6th Annual Numerof Survey Report. The report measures sentiment from c-suite executives including physician organizations or medical groups and health system executives nationwide. The report reveals minimal progress towards embracing the risk of implementing a population based strategy. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On today's episode of PopHealth Week our guest is Michael Abrams co-founder and Managing Partner of Numerof & Associates a consulting firm that notes: 'For more than 25 years, Numerof's rigorous, structured approach has solved complex strategic and operational problems for clients in industries in transition.' We discuss the key take aways of their recent report titled:"State of Population Health: The 6th Annnual Numerof Survey Report'.The report measures sentiment from c-suite executives including physician organizations or medical groups and health system executives nationwide. The report reveals minimal progress towards embracing the riskof implementing a population based strategy. Over the last 25 years Michael has built a portfolio of strategy and business performance successes as an internal and external consultant to Fortune 500 corporations. Leveraging the corporate management experience he acquired prior to founding Numerof, Michael has shaped the development of Numerof's approach, including the firm's emphasis on innovative and realistic strategies for changing markets, as well as rigor in managing the complex change necessary for improving organizational performance. Michael completed his doctoral work in business policy at St. Louis University and received his MA degree from George Washington University in Washington, DC. He co-authored Bringing Value to Healthcare: Practical Steps for Getting to a Market-Based Model, and his articles have appeared in more than a dozen leading business journals. Enjoy! ==##==  

On this episode of Managed Care Cast, we speak with Michael Abrams, managing partner at Numerof & Associates, on persistent barriers to entry for generics entering the pharmaceutical market, the impact of antitrust laws issued by the Biden administration, and further steps that are warranted to address anticompetitive tactics.

At WWDC this month, Apple announced new health sharing features that allow users to share their health records and patient-generated data with family, caregivers, or their healthcare provider.  On today's HIMSSCast, Michael Abrams, managing partner at Numerof & Associates, joins host Jonah Comstock to discuss the news and how it fits in the larger context of the healthcare system.Talking points:Context for Apple's latest health records announcementThe impact of the new Apple capabilitiesHow Apple is set up against the competitionApple's ecosystem playAre patients ready to own and control their health data?Are physicians ready for patient-generated health data?Injecting coaches and other stakeholders to fill the data usage gapWellness, prevention, and systemic incentivesDo tech companies see value-based care on the horizon?The rise of the "payvider"Technology and the bottom lineMore about this episode:Apple adds walking stability, family and provider health sharing, and more at WWDC 2021Apple's new health data sharing feature is part of the patient-controlled data trendApple Health Records launches out of beta with 39 health systemsHow patient-generated data contributes to clinician burnoutThe real-time health system: Adapting healthcare to the new normal

Guests: John Lott, President of the Crime Prevention Research Center, On to discuss voting security. Michael Abrams, Co-founder of Numerof & Associates, On to discuss how fedreal relief for hospitals is failing those in rural areas. And ... Your thoughts on the origins of COVID-19 See omnystudio.com/listener for privacy information.

It didn’t take a pandemic to prove that the U.S. health care system is broken, but this year’s COVID-19 outbreak certainly provided more evidence of what we all knew. To fix it, we need to “change the entire game,” says Rita Numerof, president and co-founder of the health care consulting firm, Numerof & Associates.

In this episode, we are joined by Michael Abrams, Managing Partner of Numerof & Associates, to discuss the effects of COVID-19 on healthcare and its lasting impact.   Learn how to listen to The Hospital Finance Podcast® on your mobile device. Highlights of this episode include: A review of the multitude of issues in our healthcare Read More

In this episode of Managed Care Cast, we talk with Michael N. Abrams, a cofounder and managing partner of Numerof & Associates, about the fifth annual report on the state of population health.

Healthcare is changing due to a combination of technological improvements and rising costs. For instance, more than half of surgical procedures now take place in an outpatient environment, but, as with many things in healthcare, there isn’t a lot of transparency. Today on Managed Care Cast, we speak with Michael Abrams, managing partner of Numerof & Associates, about patient safety and outpatient settings.

On this week's Tech Nation, Mikko Hyppönen, the Chief Research Officer at F-Secure. Cybersecurity in the world today, as well as Hypponen's Law. Then, the new approach taken with first Post-Partum depression drug. Dr. Jeff Jonas, the CEO of Sage Therapeutics, tells us how it just may work for depression in general. And finally, why do these drugs cost so much? Mike Abrams from Numerof and Associates explains.

On this week’s Tech Nation, Mikko Hyppönen, the Chief Research Officer at F-Secure. Cybersecurity in the world today, as well as Hypponen’s Law. Then, the new approach taken with first Post-Partum depression drug. Dr. Jeff Jonas, the CEO of Sage Therapeutics, tells us how it just may work for depression in general. And finally, why do these drugs cost so much? Mike Abrams from Numerof and Associates explains.

In this episode, we are joined by Michael Abrams, Managing Partner at Numerof & Associates, to discuss the state of population health in the United States. Learn how to listen to The Hospital Finance Podcast® on your mobile device. Highlights of this episode include: Background on Numerof’s study on the evolution of population health management Read More

At PopHealth Week on Wednesday, May 15th at 12 Noon Pacific/3PM Eastern our special guest was Rita Numerof, PhD, President and Co-founder at Numerof & Associates. More about RIta: "Her dedication, leadership, and passion have guided Numerof into its third decade of continuous growth and success. From the firm’s inception, Rita has focused on developing new business models for companies in industries undergoing major market changes. Her work has spanned industries that are critical to global economic growth – financial services, healthcare delivery, pharmaceuticals, medical devices, telecommunications, and major industrial manufacturing. Bringing experience, style, and boundless energy, Rita has applied her expertise to help organizations create and execute successful new strategies in the face of fundamental market shifts." "Rita has a deep understanding of the challenges executives face in sustaining growth and profitability in increasingly fluid markets. As a result, she’s become a trusted advisor to senior management teams across a wide range of leading companies. Her cross-industry perspective, combined with her expertise in executing strategy and optimizing corporate performance are the basis for objective counsel that leading executives rely on." Join us!

Wednesday, May 15th at 12 Noon Pacific/3PM Eastern our special guest is Rita Numerof, PhD, President and Co-founder at Numerof & Associates. More about RIta: Her dedication, leadership, and passion have guided Numerof into its third decade of continuous growth and success. From the firm’s inception, Rita has focused on developing new business models for companies in industries undergoing major market changes. Her work has spanned industries that are critical to global economic growth – financial services, healthcare delivery, pharmaceuticals, medical devices, telecommunications, and major industrial manufacturing. Bringing experience, style, and boundless energy, Rita has applied her expertise to help organizations create and execute successful new strategies in the face of fundamental market shifts. Rita has a deep understanding of the challenges executives face in sustaining growth and profitability in increasingly fluid markets. As a result, she’s become a trusted advisor to senior management teams across a wide range of leading companies. Her cross-industry perspective, combined with her expertise in executing strategy and optimizing corporate performance are the basis for objective counsel that leading executives rely on. Join us!

On this week’s Tech Nation, Mikko Hyppönen, the Chief Research Officer at F-Secure. Cybersecurity in the world today, as well as Hypponen’s Law. Then, the new approach taken with first Post-Partum depression drug. Dr. Jeff Jonas, the CEO of Sage Therapeutics, tells us how it just may work for depression in general. And finally, why do these drugs cost so much? Mike Abrams from Numerof and Associates explains.

On this week’s Tech Nation, Mikko Hyppönen, the Chief Research Officer at F-Secure. Cybersecurity in the world today, as well as Hypponen’s Law. Then, the new approach taken with first Post-Partum depression drug. Dr. Jeff Jonas, the CEO of Sage Therapeutics, tells us how it just may work for depression in general. And finally, why do these drugs cost so much? Mike Abrams from Numerof and Associates explains.

On this week’s Tech Nation, Mikko Hyppönen, the Chief Research Officer at F-Secure. Cybersecurity in the world today, as well as Hypponen’s Law. Then, the new approach taken with first Post-Partum depression drug. Dr. Jeff Jonas, the CEO of Sage Therapeutics, tells us how it just may work for depression in general. And finally, why do these drugs cost so much? Mike Abrams from Numerof and Associates explains.

Host Dr. Bob Kaiser converses with guest Dr. Rita Numerof, founder and CEO of St. Louis-based Numerof and Associates, about the transition from fee-for-service to market-based models in healthcare. They also discuss healthcare disruptors such as the partnerships between Amazon- JPMorgan Chase-Berkshire Hathaway, CVS-Aetna and Walgreens Humana.

The United States healthcare system is about to undergo some changes. The proposed cross-sector merger between CVS Health and Aetna created some waves and it was followed by an even bigger surprise: the partnership between Amazon, JP Morgan Chase, and Berkshire Hathaway to create a new healthcare company. Rita Numerof, PhD, the co-founder and president of Numerof & Associates, and Patricia Salber, MD, MBA, of The Doctor Weighs In, discuss the changes and the underlying factors that have led to so many attempts to shake up healthcare.